|
|
|
Volumn 26, Issue 3, 2002, Pages 256-260
|
|
Seroprevalence of hepatitis A and cost evaluation of different vaccination strategies against hepatitis A virus in patients with chronic hepatitis C in France;Séroprevalence de l'infection par le virus de l'hépatite A et évaluation du coût direct de différentes stratégies vaccinales contre le virus de l'hépatite A chez les malades atteints d'hépatite chronique C en France
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HEPATITIS A ANTIBODY;
HEPATITIS A VACCINE;
HEPATITIS C VACCINE;
HEPATITIS ANTIBODY;
ADULT;
AGE;
ANTIBODY DETECTION;
ARTICLE;
DEVICE;
DRUG COST;
FEMALE;
FRANCE;
HEPATITIS A;
HEPATITIS C;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
NATIONAL HEALTH INSURANCE;
PROSPECTIVE STUDY;
SEROPREVALENCE;
STATISTICAL ANALYSIS;
VACCINATION;
BLOOD;
COST BENEFIT ANALYSIS;
ECONOMICS;
MIDDLE AGED;
VIROLOGY;
ADULT;
COST-BENEFIT ANALYSIS;
FEMALE;
FRANCE;
HEPATITIS A;
HEPATITIS A ANTIBODIES;
HEPATITIS A VACCINES;
HEPATITIS ANTIBODIES;
HEPATITIS C, CHRONIC;
HUMANS;
MALE;
MIDDLE AGED;
|
|
EID: 0036005743
PISSN: 03998320
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (6)
|
|
References (21)
|
